Stay updated on Apalutamide Study in High-Risk Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.

Latest updates to the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe date has been updated from January 10, 2025, to February 10, 2025.SummaryDifference0.3%
- Check9 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check16 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check37 days agoChange DetectedThe website has added a new type of intervention in the latest update (v2.14.0) on January 10, 2025, while the previous version (v2.13.3) from December 6, 2024, has removed the same feature.SummaryDifference2%
- Check66 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to Apalutamide Study in High-Risk Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.